Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "ATTLAS Study of Atezolizumab + Bevacizumab & Chemo in Patients With EGFR or ALK Mutations in NSCLC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Myung-Ju Ahn
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Myung-Ju Ahn
Login to view comments.
Click here to Login
Lung